The research, published in the peer-reviewed journal Chemical Science on Wednesday, explains why dormant TB bacteria remain largely untouched during treatment and continue to persist for months despit ...
African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...
Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback